Zobrazeno 1 - 10
of 218
pro vyhledávání: '"Hiroaki Itamochi"'
Autor:
Naomi Takahashi MS, Megumi Tsubota-Utsugi RD, MPH, PhD, Shuko Takahashi MD, PhD, Yuki Yonekura PhD, Masaki Ohsawa MD, PhD, Toru Kuribayashi PhD, Toshiyuki Onoda MD, PhD, Nobuyuki Takanashi MSN, Kiyomi Sakata MD, PhD, Takehiko Yamada MT, Kuniaki Ogasawara MD, PhD, Shinichi Omama MD, PhD, Fumitaka Tanaka MD, PhD, Koichi Asahi MD, PhD, Yasushi Ishigaki MD, PhD, Ryo Itabashi MD, PhD, Hiroaki Itamochi MD, PhD, Fumiaki Takahashi PhD, Akira Okayama MD, PhD, Kozo Tanno MD, PhD
Publikováno v:
Inquiry: The Journal of Health Care Organization, Provision, and Financing, Vol 61 (2024)
Whether the association between metabolic syndrome (MetS) and functional disability differs depending on sex or age remains unknown. To determine the association between MetS and functional disability in older people separately by sex and age groups.
Externí odkaz:
https://doaj.org/article/5629749f816d4260b3b3723436222775
Publikováno v:
Clinical Case Reports, Vol 10, Iss 8, Pp n/a-n/a (2022)
Abstract This case report highlights the need for clinicians to monitor patients with rhabdomyosarcoma for pancreatic metastasis to ensure that proper treatment is quickly provided, thereby improving outcomes.
Externí odkaz:
https://doaj.org/article/e89f8dcbd2c54bd28c94a1de958a48a9
Autor:
Mizuki Hisano, Renpei Kato, Hiroaki Itamochi, Tomohiko Matsuura, Shigekatsu Maekawa, Yoichiro Kato, Mitsugu Kanehira, Ryo Takata, Tsukasa Baba, Wataru Obara
Publikováno v:
IJU Case Reports, Vol 3, Iss 5, Pp 185-188 (2020)
Introduction We report a rare case of renal cell carcinoma with vaginal metastasis that recurred with rapid progression and was resistant to sunitinib and nivolumab. Case presentation A 68‐year‐old woman presented with renal cell carcinoma and va
Externí odkaz:
https://doaj.org/article/03a4fd061ef9497cbca93760787fc261
Autor:
Kyu Kwang Kim, Rakesh K. Singh, Negar Khazan, Arif Kodza, Niloy A. Singh, Aaron Jones, Umayal Sivagnanalingam, Mary Towner, Hiroaki Itamochi, Rachael Turner, Richard G. Moore
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
Abstract Forchlorfenuron (FCF) is a synthetic plant cytokinin widely used in agriculture to promote fruit size, that paradoxically inhibits proliferation, migration, and invasion in human cancer cell lines. FCF has also been shown to affect HIF-1α a
Externí odkaz:
https://doaj.org/article/60953533fed24c108fff7feeaa994161
Autor:
Kosuke Horita, Hajime Kurosaki, Motomu Nakatake, Nozomi Kuwano, Tetsuro Oishi, Hiroaki Itamochi, Sho Sato, Hiromichi Kono, Mai Ito, Kosei Hasegawa, Tasuku Harada, Takafumi Nakamura
Publikováno v:
Molecular Therapy: Oncolytics, Vol 13, Iss , Pp 35-48 (2019)
Oncolytic vaccinia virus (OVV) has demonstrated appropriate safety profiles for clinical development. Although designed to kill cancer cells efficiently, OVV sensitivity varies in individual cancers, and predictive biomarkers of therapeutic responses
Externí odkaz:
https://doaj.org/article/54a365e194da4d77a77a032f2fc828f0
Autor:
Mitsumasa Osakabe, Chie Sato, Masamichi Suzuki, Ryo Sugimoto, Yasuko Fujita, Noriyuki Uesugi, Kazuyuki Ishida, Hiroaki Itamochi, Tsukasa Baba, Tamotsu Sugai
Publikováno v:
Diagnostic Pathology, Vol 14, Iss 1, Pp 1-5 (2019)
Abstract Background Ovarian Sertoli-Leydig cell tumors (SLCTs) with androgenic manifestations harbor DICER1 mutations in 30–60% of cases. Ovarian SLCTs without DICER1 hotspot mutations have been reported to exhibit elderly onset and no androgenic m
Externí odkaz:
https://doaj.org/article/241b751b316d48f1984484b1a79fc743
Autor:
Tadahiro Shoji, Shinichi Komiyama, Junzo Kigawa, Hiroshi Tanabe, Kazuyoshi Kato, Hiroaki Itamochi, Hiroyuki Fujiwara, Shoji Kamiura, Tetsutaro Hamano, Toru Sugiyama, for the Japanese Gynecologic Oncology Group
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
Abstract Background We present the study rationale and design of the JGOG3023 study, an open-label, parallel-arm, randomized, phase II trial that aimed to assess the efficacy and safety of chemotherapy with or without bevacizumab in patients with pla
Externí odkaz:
https://doaj.org/article/50718e1a031a4176b1c4e284b599417a
Autor:
Hiroshi Tsuda, Yoichi M Ito, Yukiharu Todo, Takahiro Iba, Keiichi Tasaka, Yuji Sutou, Kozo Hirai, Koichiro Dozono, Yoshifusa Dobashi, Mami Manabe, Tomomi Sakamoto, Ritsu Yamamoto, Katsufumi Ueda, Moe Akatsuka, Yasuhiko Kiyozuka, Nobutaka Nagai, Manami Imai, Koji Kobiki, Hiromasa Fujita, Hiroaki Itamochi, Takafumi Oshita, Takahiro Kawarada, Masayuki Hatae, Yoshihito Yokoyama
Publikováno v:
Reproductive Medicine and Biology, Vol 17, Iss 1, Pp 29-35 (2018)
Abstract Purpose To define the median endometrial thickness (ET) in office gynecology is thought to be important for clinical practice. However, there are few reports about ET that have included the general female population on a large scale. The med
Externí odkaz:
https://doaj.org/article/beb49b5c5c7443a08a09d8de70bb44e4
Autor:
Tadahiro Shoji, Shunsuke Tatsuki, Marina Abe, Hidetoshi Tomabechi, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa, Masahiro Kagabu, Tsukasa Baba, Hiroaki Itamochi
Publikováno v:
Cancers, Vol 13, Iss 23, p 6120 (2021)
Ovarian cancer has the worst prognosis among gynecological cancers. In particular, clear cell and mucinous carcinomas are less sensitive to chemotherapy. The establishment of new therapies is necessary to improve the treatment outcomes for these carc
Externí odkaz:
https://doaj.org/article/d3e6e524383e4539a60a813b4c59a8af
Autor:
Bart Kolendowski, Yudith Ramos Valdes, Hal Hirte, Hiroaki Itamochi, Wonjae Lee, Mark Carey, Trevor G. Shepherd, Gabriel E. DiMattia
Publikováno v:
Cells, Vol 9, Iss 11, p 2408 (2020)
Ovarian clear cell carcinoma (OCCC) is a rare subtype of gynecological cancer for which well-characterized and authenticated model systems are scarce. We provide an extensive characterization of ‘105C’, a cell line generated from an adenocarcinom
Externí odkaz:
https://doaj.org/article/8c7b852cf47e41318576b9c8f4297d14